1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Head And Neck Carcinoma Global Clinical Trials Review, H1, 2014

Head And Neck Carcinoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Head And Neck Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Head And Neck Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Head And Neck Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Head And Neck Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Head And Neck Carcinoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Head and Neck Carcinoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Head And Neck Carcinoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Head And Neck Carcinoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Head And Neck Carcinoma 25
Subjects Recruited Over a Period of Time 34
Clinical Trials by Sponsor Type 35
Prominent Sponsors 36
Top Companies Participating in Head And Neck Carcinoma Therapeutics Clinical Trials 37
Prominent Drugs 38
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
Sanofi 39
Clinical Trial Overview of Sanofi 39
AstraZeneca PLC 42
Clinical Trial Overview of AstraZeneca PLC 42
E. Merck KG 44
Clinical Trial Overview of E. Merck KG 44
F. Hoffmann-La Roche Ltd. 46
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 46
Novartis AG 48
Clinical Trial Overview of Novartis AG 48
Eli Lilly and Company 49
Clinical Trial Overview of Eli Lilly and Company 49
Amgen Inc. 50
Clinical Trial Overview of Amgen Inc. 50
Pfizer Inc. 51
Clinical Trial Overview of Pfizer Inc. 51
Celgene Corporation 52
Clinical Trial Overview of Celgene Corporation 52
C. H. Boehringer Sohn AG and Co. KG 53
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 53
Clinical Trial Overview of Top Institutes / Government 54
National Cancer Institute 54
Clinical Trial Overview of National Cancer Institute 54
European Organization for Research and Treatment of Cancer 62
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 62
The University of Texas M. D. Anderson Cancer Center 65
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 65
Memorial Sloan Kettering Cancer Center 67
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 67
Radiation Therapy Oncology Group 69
Clinical Trial Overview of Radiation Therapy Oncology Group 69
University of Pittsburgh 70
Clinical Trial Overview of University of Pittsburgh 70
Sidney Kimmel Comprehensive Cancer Center 71
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 71
The University of Chicago 72
Clinical Trial Overview of The University of Chicago 72
Groupe Oncologie Radiotherapie Tete et Cou 73
Clinical Trial Overview of Groupe Oncologie Radiotherapie Tete et Cou 73
Five Key Clinical Profiles 74
Appendix 179
Abbreviations 179
Definitions 179
Research Methodology 180
Secondary Research 180
About GlobalData 181
Contact Us 181
Disclaimer 181
Source 182

List of Tables
Head And Neck Carcinoma Therapeutics, Global, Clinical Trials by Region, 2014* 7
Head And Neck Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Head And Neck Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Head And Neck Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Head And Neck Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Head And Neck Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Head And Neck Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Head And Neck Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Head And Neck Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Head And Neck Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Head And Neck Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Head And Neck Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Head And Neck Carcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Head And Neck Carcinoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Head And Neck Carcinoma Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Head And Neck Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Head And Neck Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Head And Neck Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Head And Neck Carcinoma Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Head And Neck Carcinoma Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Head And Neck Carcinoma Therapeutics, Global, Terminated Clinical Trials, 2014* 28
Head And Neck Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 34
Head And Neck Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 35
Head And Neck Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 36
Head And Neck Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 37
Head And Neck Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 38
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 39
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 42
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014* 44
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 46
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 48
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 49
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 50
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 51
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014* 52
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2014* 53
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 54
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 62
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 65
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 67
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2014* 69
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 70
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2014* 71
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2014* 72
Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe Oncologie Radiotherapie Tete et Cou, 2014* 73

List of Figures
Head And Neck Carcinoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Head And Neck Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Head And Neck Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Head And Neck Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Head And Neck Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Head And Neck Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Head And Neck Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Head And Neck Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Head And Neck Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Head And Neck Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Head And Neck Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Head And Neck Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Head And Neck Carcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Head And Neck Carcinoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Head And Neck Carcinoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Head And Neck Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Head And Neck Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Head And Neck Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 34
Head And Neck Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 35
Head And Neck Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 36
Head And Neck Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 37
Head And Neck Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 38
GlobalData Methodology 180

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.